Publications
Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.
* denotes publications from the CTD2 initiative that are results of intra-Network collaborations
CTD²
August 01, 2020
J Mol Cell Biol.
CTD²
August 01, 2020
Nat Protoc.
CTD²
July 27, 2020
Nucleic Acids Res.
CTD²
July 22, 2020
Nature Communications
CTD²
July 01, 2020
Mol Syst Biol.
CTD²
June 30, 2020
Biochem Soc Trans.
CTD²
June 11, 2020
Blood
Study highlights the usage of FDA-approved tyrosine kinase inhibitors for treating leukemia patients with neurotrophic receptor tyrosine kinase mutations.
CTD²
June 01, 2020
Nature Chemical Biology
Integrated analysis of RNA-sequencing, proteomics, and phosphoproteomics data indicate doublecortin like kinase 1 (DCLK1) modulates proteins and pathways associated with cell motility in patient-derived pancreatic ductal adenocarcinoma (PDAC) organoids.
Pages
